{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:50:23Z","timestamp":1793155823690,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["208750\/Z\/17\/Z"],"award-info":[{"award-number":["208750\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ajhg.2023.08.010","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T10:30:16Z","timestamp":1693564216000},"page":"1817-1824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background"],"prefix":"10.1016","volume":"110","author":[{"given":"Cong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Shestopaloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Hei","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengeng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Marie","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Readie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruvie","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Beste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Zierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vandemeulebroecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2475-3969","authenticated-orcid":false,"given":"Luke","family":"Jostins-Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajhg.2023.08.010_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.63","article-title":"Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management","volume":"7","author":"Roda","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.ajhg.2023.08.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41397-022-00290-8","article-title":"Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?","volume":"23","author":"Curry","year":"2023","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.ajhg.2023.08.010_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12967-021-02910-6","article-title":"Translational precision medicine: an industry perspective","volume":"19","author":"Hartl","year":"2021","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ajhg.2023.08.010_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41584-022-00845-w","article-title":"Precision medicine: the precision gap in rheumatic disease","volume":"18","author":"Lin","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ajhg.2023.08.010_bib5","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1038\/s41467-022-30675-z","article-title":"The potential of polygenic scores to improve cost and efficiency of clinical trials","volume":"13","author":"Fahed","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.08.010_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"12","author":"Lewis","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.ajhg.2023.08.010_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2022.02.015","article-title":"The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic Review","volume":"304","author":"Meerman","year":"2022","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.ajhg.2023.08.010_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ajhg.2023.08.010_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.micinf.2019.06.009","article-title":"The IL-23\/IL-17 pathway in human chronic inflammatory diseases - new insight from genetics and targeted therapies","volume":"21","author":"Bianchi","year":"2019","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ajhg.2023.08.010_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrg3502","article-title":"Genetic insights into common pathways and complex relationships among immune-mediated diseases","volume":"14","author":"Parkes","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ajhg.2023.08.010_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13073-020-00797-4","article-title":"Genetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases","volume":"12","author":"Burren","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.ajhg.2023.08.010_bib12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/annrheumdis-2012-202405","article-title":"Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis","volume":"72","author":"Umi\u010bevi\u010b Mirkov","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ajhg.2023.08.010_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41397-018-0040-6","article-title":"Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis","volume":"18","author":"Massey","year":"2018","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.ajhg.2023.08.010_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.gastro.2019.09.041","article-title":"HLA-DQA1\u221705 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn\u2019s Disease","volume":"158","author":"Sazonovs","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajhg.2023.08.010_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003348","article-title":"Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium","volume":"17","author":"H\u00e4ssler","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.ajhg.2023.08.010_bib16","article-title":"Identification of HLA-DRB1 association to adalimumab immunogenicity","volume":"13","author":"Liu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ajhg.2023.08.010_bib17","series-title":"BEST (Biomarkers, Endpoints, and Other Tools) Resource. 2016","year":"2016"},{"key":"10.1016\/j.ajhg.2023.08.010_bib18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis--results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ajhg.2023.08.010_bib19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/annrheumdis-2017-212687","article-title":"Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study","volume":"77","author":"Mease","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ajhg.2023.08.010_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13075-017-1490-y","article-title":"Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3","volume":"19","author":"Pavelka","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ajhg.2023.08.010_bib21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/art.40070","article-title":"Secukinumab in active rheumatoid arthritis: A phase III randomized, double-blind, active comparator- and placebo-controlled study","volume":"69","author":"Blanco","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ajhg.2023.08.010_bib22","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/jdv.16180","article-title":"Real-world evidence of secukinumab in psoriasis treatment - a meta-analysis of 43 studies","volume":"34","author":"Augustin","year":"2020","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ajhg.2023.08.010_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/kev258","article-title":"Association of HLA-DRB1 alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis","volume":"55","author":"Burmester","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.ajhg.2023.08.010_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221090310","article-title":"Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study","volume":"14","author":"Ramonda","year":"2022","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.ajhg.2023.08.010_bib25","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/bjd.16705","article-title":"Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study","volume":"179","author":"Costanzo","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ajhg.2023.08.010_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/14712598.2021.1862082","article-title":"HLA-Cw6 and other HLA-C alleles, as well as MICB-DT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis","volume":"21","author":"Morelli","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ajhg.2023.08.010_bib27","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.49.11.916","article-title":"Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score","volume":"49","author":"van der Heijde","year":"1990","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ajhg.2023.08.010_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/rheumatology\/35.9.867","article-title":"DISEASE ACTIVITY IN ANKYLOSING SPONDYLTTIS: SELECTION OF A CORE SET OF VARIABLES AND A FIRST STEP IN THE DEVELOPMENT OF A DISEASE ACTIVITY SCORE","volume":"35","author":"Creemers","year":"1996","journal-title":"Rheumatology"},{"key":"10.1016\/j.ajhg.2023.08.010_bib29","first-page":"238","article-title":"Severe psoriasis\u2013oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatology"},{"key":"10.1016\/j.ajhg.2023.08.010_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.08.010_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/gepi.21944","article-title":"A framework for interpreting type I error rates from a product-term model of interaction applied to quantitative traits","volume":"40","author":"Rao","year":"2016","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.ajhg.2023.08.010_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019416","article-title":"Behavior of QQ-plots and genomic control in studies of gene-environment interaction","volume":"6","author":"Voorman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajhg.2023.08.010_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0167-9473(02)00366-3","article-title":"Asymptotic inference under heteroskedasticity of unknown form","volume":"45","author":"Cribari-Neto","year":"2004","journal-title":"Comput. Stat. Data Anal."},{"key":"10.1016\/j.ajhg.2023.08.010_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.3211","article-title":"LD Score regression distinguishes confounding from polygenicity in genome-wide association studies","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.08.010_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13059-021-02403-1","article-title":"GxEsum: a novel approach to estimate the phenotypic variance explained by genome-wide GxE interaction based on GWAS summary statistics for biobank-scale data","volume":"22","author":"Shin","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.ajhg.2023.08.010_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000099183","article-title":"Exploiting gene-environment interaction to detect genetic associations","volume":"63","author":"Kraft","year":"2007","journal-title":"Hum. Hered."},{"key":"10.1016\/j.ajhg.2023.08.010_bib37","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1038\/s41467-022-32407-9","article-title":"Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods","volume":"13","author":"Zhai","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.08.010_bib38","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1093\/rheumatology\/keac073","article-title":"Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritis","volume":"61","author":"\u00d8stergaard","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.ajhg.2023.08.010_bib39","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2023.08.010_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.08.010_bib41","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.08.010_bib42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/annrheumdis-2020-219065","article-title":"Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci","volume":"80","author":"Ha","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ajhg.2023.08.010_bib43","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.08.010_bib44","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/gutjnl-2019-318835","article-title":"IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn\u2019s and Colitis","volume":"68","author":"Parkes","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.ajhg.2023.08.010_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41584-022-00748-w","article-title":"HIPPOCRATES: improving diagnosis and outcomes in psoriatic arthritis","volume":"18","author":"FitzGerald","year":"2022","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929723002860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929723002860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:58:54Z","timestamp":1783025934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929723002860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0002929723002860"],"URL":"https:\/\/doi.org\/10.1016\/j.ajhg.2023.08.010","relation":{},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Human Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajhg.2023.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}]}}